I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 3.9 USD -6.7% Market Closed
Market Cap: 315.4m USD

Wall Street
Price Targets

IMAB Price Targets Summary
I-Mab

Wall Street analysts forecast IMAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMAB is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Lowest
Price Target
6.06 USD
55% Upside
Average
Price Target
7.14 USD
83% Upside
Highest
Price Target
8.4 USD
115% Upside
I-Mab Competitors:
Price Targets
DSGN
Design Therapeutics Inc
26% Upside
BCRX
BioCryst Pharmaceuticals Inc
123% Upside
002007
Hualan Biological Engineering Inc
17% Upside
CRBU
Caribou Biosciences Inc
373% Upside
MGNX
MacroGenics Inc
110% Upside
IMMX
Immix Biopharma Inc
222% Upside

Revenue
Forecast

Revenue Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
I-Mab

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMAB's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for IMAB is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Back to Top